Using stated-preferences methods to develop a summary metric to determine successful treatment of children with a surgical condition: a study protocol.
HEALTH ECONOMICS
HEALTH SERVICES ADMINISTRATION & MANAGEMENT
PAEDIATRIC SURGERY
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
09 06 2022
09 06 2022
Historique:
entrez:
9
6
2022
pubmed:
10
6
2022
medline:
14
6
2022
Statut:
epublish
Résumé
Wide variation in the management of key paediatric surgical conditions in the UK has likely resulted in outcomes for some children being worse than they could be. Consequently, it is important to reduce unwarranted variation. However, major barriers to this are the inability to detect differences between observed and expected hospital outcomes based on the casemix of the children they have treated, and the inability to detect variation in significant outcomes between hospitals. A stated-preference study has been designed to estimate the value key stakeholders place on different elements of the outcomes for a child with a surgical condition. This study proposes to develop a summary metric to determine what represents successful treatment of children with surgical conditions. Preferences from parents, individuals treated for surgical conditions as infants/children, healthcare professionals and members of the public will be elicited using paired comparisons and kaizen tasks. A descriptive framework consisting of seven attributes representing types of operations, infections treated in hospital, quality of life and survival was identified. An experimental design has been completed using a D-efficient design with overlap in three attributes and excluding implausible combinations. All participants will be presented with an additional choice task including a palliative scenario that will be used as an anchor. The survey will be administered online. Primary analysis will estimate a mixed multinomial logit model. A traffic light system to determine what combination of attributes and levels represent successful treatment will be created. Ethics approval to conduct this study has been obtained from the Medical Sciences Inter-Divisional Research Ethics Committee (IDREC) at the University of Oxford (R59631/RE001-05). We will disseminate all of our results in peer-review publications and scientific presentations. Findings will be additionally disseminated through relevant charities and support groups and professional organisations.
Identifiants
pubmed: 35680263
pii: bmjopen-2022-062833
doi: 10.1136/bmjopen-2022-062833
pmc: PMC9185585
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e062833Subventions
Organisme : Department of Health
Pays : United Kingdom
Investigateurs
Alexander Macdonald
(A)
Anna May Long
(AM)
Gregor Walker
(G)
Kokila Lakhoo
(K)
Nigel Hall
(N)
Nick Lansdale
(N)
Simon Kenny
(S)
Stefano Giuliani
(S)
Timothy Bradnock
(T)
Joanne Shepherd
(J)
Karolina Kuberska
(K)
Lisa Hinton
(L)
Goher Ayman
(G)
Benjamin Allin
(B)
Charles Opondo
(C)
Crispin Jenkinson
(C)
John Buckell
(J)
Marian Knight
(M)
Rema Ramakrishnan
(R)
Oliver Rivero-Arias
(O)
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Pharmacoeconomics. 2017 Jul;35(7):697-716
pubmed: 28374325
J Pediatr Surg. 2019 Feb;54(2):313-317
pubmed: 30528203
Pharmacoeconomics. 2019 Feb;37(2):201-226
pubmed: 30392040
Value Health. 2014 Nov;17(7):A515-6
pubmed: 27201597
Patient. 2019 Jun;12(3):287-295
pubmed: 30906968
J Pediatr Surg. 2010 Sep;45(9):1808-16
pubmed: 20850625
Patient. 2022 Mar;15(2):187-196
pubmed: 34327605
J Pediatr Surg. 2019 Feb;54(2):318-321
pubmed: 30528204
Arch Dis Child Fetal Neonatal Ed. 2019 Nov;104(6):F643-F647
pubmed: 31154421
Arch Dis Child Fetal Neonatal Ed. 2019 Jan;104(1):F76-F82
pubmed: 29540463
Trials. 2012 Jul 02;13:103
pubmed: 22747787
J Health Econ. 2009 Dec;28(6):1039-47
pubmed: 19833400
Value Health. 2016 Jun;19(4):300-15
pubmed: 27325321
Arch Dis Child. 2017 Dec;102(12):1143-1151
pubmed: 28784616
Br J Surg. 2020 Jul;107(8):1013-1022
pubmed: 32181505
Arch Dis Child Fetal Neonatal Ed. 2018 Sep;103(5):F461-F466
pubmed: 29092912
Value Health. 2011 Jun;14(4):403-13
pubmed: 21669364
PLoS One. 2014 Aug 25;9(8):e106149
pubmed: 25153838
Contemp Clin Trials. 2020 Apr;91:105968
pubmed: 32147572
Thyroid. 2020 Jul;30(7):1044-1052
pubmed: 32143553
Patient. 2020 Feb;13(1):121-136
pubmed: 31840215
BMJ Open. 2019 Jul 3;9(7):e029406
pubmed: 31272981
Value Health. 2013 Jan-Feb;16(1):3-13
pubmed: 23337210
Br J Surg. 2013 Mar;100(4):515-21
pubmed: 23334932
Health Qual Life Outcomes. 2021 Sep 23;19(1):222
pubmed: 34556133
BJS Open. 2019 Jan 31;3(3):305-313
pubmed: 31183446
Arch Dis Child Fetal Neonatal Ed. 2018 Nov;103(6):F517-F522
pubmed: 29305406
Arch Dis Child. 2017 Aug;102(8):722-727
pubmed: 28280094
Arch Dis Child. 2020 Nov 2;:
pubmed: 33139346
Health Econ. 2016 Jun;25(6):768-77
pubmed: 25926161
BMJ. 2011 Nov 15;343:d6749
pubmed: 22089731
Trials. 2017 Jun 20;18(Suppl 3):280
pubmed: 28681707
Value Health. 2016 Jun;19(4):316-22
pubmed: 27325322
Ann Surg. 2021 Jun 1;273(6):1207-1214
pubmed: 33201118
J Pediatr Surg. 2017 Feb;52(2):226-230
pubmed: 27894760
Pharmacoeconomics. 2020 Apr;38(4):325-340
pubmed: 31903522
Sci Rep. 2017 Jan 27;7:41149
pubmed: 28128283
Arch Dis Child Fetal Neonatal Ed. 2020 Jul;105(4):425-431
pubmed: 31732683